ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Financial toxicity trajectories and their association with short-term and long-term health outcomes in Chinese patients with cancer: a prospective cohort study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThe trajectories of financial toxicity and their associations with short- and long-term health outcomes remain poorly characterized. This study aimed to identify distinct financial toxicity trajectories and to evaluate their associations with health outcomes among Chinese patients with cancer.
methodsWe recruited patients with newly diagnosed cancer from three tertiary cancer hospitals between March 2017 and December 2018 and followed the cohort until March 12, 2021. The Comprehensive Score for Financial Toxicity (COST) and health-related quality of life (HRQoL) were assessed at baseline, 6 months, and 12 months. Group-based trajectory model (GBTM) was applied to identify distinct financial toxicity trajectories based on COST scores. Linear mixed models were fitted to estimate the average effect size, examining the association between COST trajectory groups and HRQoL. Cox proportional hazards models were used to evaluate the association between financial toxicity trajectories and all-cause mortality.
resultsThree trajectories of financial toxicity were identified: a "low rising-declining" group (26.18%), a "moderately stable"group (62.91%), and an "elevated decreasing-rising"group (10.91%). Compared with the low rising-declining trajectory group, both the moderately stable trajectory group (β = 6.86, 95% CI 3.75-9.98; P < 0.001) and the elevated decreasing-rising trajectory group (β = 12.43, 95% CI 8.05-16.81; P < 0.001) had significantly higher HRQoL scores. After multivariable adjustment for demographic and clinical covariates, no significant association was observed between financial toxicity trajectory groups and all-cause mortality.
conclusionsFinancial toxicity tends to follow a moderately stable trajectory and persists throughout cancer treatment. It also excerts an adverse effect on HRQoL. Further investigation is needed to clarify the association between financial toxicity trajectories and long-term survival among patients with cancer.
Indexed as
Identifiers
42053815What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.